Clomiphene Citrate Protocol for Discontinuing Testosterone Replacement Therapy

Introduction to Clomiphene Citrate Transition

• The American Urological Association, Endocrine Society, and American College of Physicians have not published formal protocols for transitioning from testosterone replacement therapy (TRT) to clomiphene citrate 1
• Guidelines from major societies focus on when to initiate or continue TRT, but not on discontinuation protocols, as noted by the Mayo Clinic Proceedings 2, 3

Pre-Transition Assessment and Monitoring

• Bone mineral density and fracture risk should be assessed before attempting clomiphene transition, as clomiphene may have implications for bone health, according to Praxis Medical Insights 1
• Monitoring of hematocrit, PSA, and digital rectal examination should be performed per standard TRT monitoring, as recommended by the New England Journal of Medicine 4

Safety and Efficacy of Clomiphene Citrate

• Clomiphene citrate is significantly safer than TRT, with a lower risk of polycythemia, and does not carry the same bone loss concerns as anastrozole, as noted by Praxis Medical Insights 1